5624 results for "canc*"

in 16.53 milliseconds.

• Tumour sample for patient SA718

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA718

  Dataset EGAD00001009584

• Tumour sample for patient SA720

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA720

  Dataset EGAD00001009585

• Normal sample for patient SA1017

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA1017

  Dataset EGAD00001009586

• Normal sample for patient SA1026

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA1026

  Dataset EGAD00001009587

• Normal sample for patient SA1027

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA1027

  Dataset EGAD00001009588

• Normal sample for patient SA1028

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA1028

  Dataset EGAD00001009589

• Normal sample for patient SA1040

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA1040

  Dataset EGAD00001009590

• Normal sample for patient SA1064

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA1064

  Dataset EGAD00001009591

• Normal sample for patient SA1065

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA1065

  Dataset EGAD00001009592

• Normal sample for patient SA415

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA415

  Dataset EGAD00001009603

• Normal sample for patient SA1069

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA1069

  Dataset EGAD00001009593

• Normal sample for patient SA1073

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA1073

  Dataset EGAD00001009594

• Normal sample for patient SA1074

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA1074

  Dataset EGAD00001009595

• Normal sample for patient SA576

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA576

  Dataset EGAD00001009596

• Normal sample for patient SA610

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA610

  Dataset EGAD00001009597

• Normal sample for patient SA992

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA992

  Dataset EGAD00001009598

• Normal sample for patient SA994

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA994

  Dataset EGAD00001009599

• Normal sample for patient SA288

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA288

  Dataset EGAD00001009601

• Normal sample for patient SA299

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA299

  Dataset EGAD00001009602

• Normal sample for patient SA666

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA666

  Dataset EGAD00001009604

• Tumour sample for patient SA1065

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA1065

  Dataset EGAD00001009605

• Tumour sample for patient SA1064

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA1064

  Dataset EGAD00001009606

• Tumour sample for patient SA1026

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA1026

  Dataset EGAD00001009607

• Tumour sample for patient SA1069

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA1069

  Dataset EGAD00001009608

• Tumour sample for patient SA1017

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA1017

  Dataset EGAD00001009609

• Tumour sample for patient SA1027

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA1027

  Dataset EGAD00001009610

• Tumour sample for patient SA1073

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA1073

  Dataset EGAD00001009611

• Tumour sample for patient SA997

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA997

  Dataset EGAD00001009621

• Tumour sample for patient SA1074

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA1074

  Dataset EGAD00001009612

• Tumour sample for patient SA576

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA576

  Dataset EGAD00001009613

• Tumour sample for patient SA1028

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA1028

  Dataset EGAD00001009614

• Tumour sample for patient SA1040

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA1040

  Dataset EGAD00001009615

• Tumour sample for patient SA992

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA992

  Dataset EGAD00001009616

• Tumour sample for patient SA610

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA610

  Dataset EGAD00001009617

• Normal sample for patient SA416

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA416

  Dataset EGAD00001009618

• Normal sample for patient SA1070

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA1070

  Dataset EGAD00001009619

• Tumour sample for patient SA1070

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA1070

  Dataset EGAD00001009620

• MethylationEPIC_850K

  This dataset includes IDAT files from 160 samples (57 primary prostate cancers, 95 proste-derived brain metastases, and 7 normal tissues). The samples were profiled using the Illumina Infinium MethylationEPIC BeadChips (850K)

  Dataset EGAD00010002372

• WGS of primary mesothelioma cell lines

  Mesothelioma is an aggressive cancer associated with previous exposure to asbestos and dismal prognosis. Since a pemetrexed/cisplatin combination was introduced for treatment of mesothelioma, no new first- or second-line therapies have been discovered. Thus, to better understand what drives mesothelioma carcinogenesis and to identify potential targets for therapy, in this project we aim at performing WGS analysis of a panel of mesothelioma cells lines.

  Dataset EGAD00001009641

• Single Cell Genome Sequence for DLP+ library A96228A

  Single Cell Genome Sequence for Immortalized lymphoblastoid cell line GM18507 cell line SA928,Triple negative breast cancer patient-derived xenograft SA609 passage 2 patient-derived xenograft SA609 passage 2 on DLP+ library A96228A

  Dataset EGAD00001009645

• Single Cell Genome Sequence for DLP+ library A98247A

  Single Cell Genome Sequence for triple negative breast cancer patient-derived xenograft SA530 passage 3 on DLP+ library A98247A

  Dataset EGAD00001009646

• Nanopore low-pass WGS of human brain tumors

  Nanopore low-pass WGS of human brain tumors for evaluation of DNA methylation-based classification of cancer

  Dataset EGAD00001009663

• The University of Hong Kong Colon Cancer Ganciclovir Study WGS Data

  Human clonal intestinal organoids were treated with 1µM MMF (Roche), 20 μM GCV (Hainan Poly Pharm Co Ltd), or in combinations (1 µM MMF + 20 μM GCV or 1 µM MMF + 40 μM GCV) continuously for 4-6 weeks. DNA was extracted after drug treatment. WGS was performed with 150 bp PE sequencing at 30X using an Illumina Novaseq sequencer.

  Dataset EGAD00001009667

• Tumour sample for patient SA1058

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA1058

  Dataset EGAD00001009673

• Normal sample for patient SA1058

  Whole genome sequencing of normal sample for triple negative breast cancer patient SA1058

  Dataset EGAD00001009672

• Tumour sample for patient SA998

  Whole genome sequencing of tumour sample for triple negative breast cancer patient SA998

  Dataset EGAD00001009674

• Variants from germline WES data of pediatric cancer patients

  This dataset contains germline variants (in .vcf format) from six pediatric cancer patients (sample IDs D1 - D6). WES data of the children and their parents was mapped to hg38. A consensus of four variant callers was used to obtain germline variants of the children.

  Dataset EGAD00001009678

• pan-cancer plasma cfRNA

  Dataset contains mRNA capture sequencing data from plasma of 266 different human donors. The first, pan-cancer, cohort covers 25 high-grade to metastatic cancer types (8 cancer patients per type) and a control group (8 healthy donors). The validation cohort comprises additional plasma samples from ovarian, prostate and uterine cancer patients (12 per type) as well as additional samples from controls (22 new and 8 repeated). Samples were sequenced on a NovaSeq 6000 and are provided in FASTQ format.

  Dataset EGAD00001009713

• 2 paired WGS samples of peritumour regions of colorectal cancer

  2 paired WGS samples of peritumour regions of colorectal cancer (2 patients). The library was prepared using the Illumina TruSeq Nano FFPE kit and the sequencing was done on NovaSeq6000.

  Dataset EGAD00001009714

• PGDx elio plasma resolve analytical validation

  This dataset consists of 39 noncancerous donor and 62 cancer patient plasma samples (including 29 patients with CRC across a total of 13 tumor types) that were analyzed with the PGDx elio plasma resolve assay. The PGDx elio plasma resolve assay is a hybrid capture approach targeting 33 genes with sequencing performed using the Illumina NextSeq with 150bp paired-end reads. The bam files provided have been adapter masked and contain duplicate reads.

  Dataset EGAD00001009718